CDKL5 Deficiency Disorder Clinical Trial
Official title:
Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in Children With CDKL5 Deficiency: A Single-center, Self Control Trial
The primary objective of this research is to study the efficacy and safety of hyperthermic baths as adjunctive therapy for reducing the frequency of seizures in CDKL5 deficiency.
This project aims to include 8 participants, and evaluate the effectiveness and safety of hyperthermic baths in patients with CDKL5 deficiency through A single-center, preliminary feasibility clinical trial. It is expected to provide new therapeutic options for patients with CDKL5 deficiency with alternative treatment options. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05064878 -
A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder
|
Phase 3 | |
| Completed |
NCT03572933 -
Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder
|
Phase 3 | |
| Not yet recruiting |
NCT05249556 -
Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
|
Phase 3 | |
| Recruiting |
NCT05558371 -
International CDKL5 Clinical Research Network
|